Ampulla of Vater Carcinoma — Trials

Ampulla of Vater Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

43 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 19
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: Minia University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01208103	Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma	completed	Phase 2	30	M.D. Anderson Cancer CenterOTHER	1	Sep 3, 2020	clinicaltrials
NCT00753675	Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer(VANGOGH)	completed	Phase 2	174	Genzyme, a Sanofi CompanyINDUSTRY	1	Oct 10, 2016